文献速递精神分裂症与精神病性障碍老年精神

精神分裂症与加速衰老:系统综述及未来研究方向

Schizophrenia and accelerated ageing: systematic review and future research directions.
PubMed 文献 · Br J Psychiatry · 2026-04-22

该系统综述评估精神分裂症是否在多个生物系统表现出加速或提前衰老表型,并评估分子机制一致性。纳入170篇文献,发现死亡率和痴呆风险升高、脑预测年龄差3-4年、端粒缩短等可重复衰老表型,支持提前而非均匀加速衰老模型。

要点

  • 精神分裂症患者死亡率和痴呆风险升高,脑预测年龄差平均3-4年,首发时即可出现。
  • 荟萃分析显示端粒缩短(标准化均数差约-0.4至-0.5)及部分表观遗传时钟轻度加速。
  • 氧化应激、炎症、线粒体功能及IGF-1信号失调常见,部分早于抗精神病药暴露。

核心结论

  • 精神分裂症与多系统衰老表型相关,由汇聚的生物学机制支撑,最一致涉及端粒磨损及氧化和/或炎症应激。
  • 整体模式支持提前衰老而非均匀加速衰老模型,反映早期生物学偏离后平行而非更陡下降。

研究设计与样本

  • 系统综述遵循PRISMA指南,注册号PROSPERO CRD42024574059,检索PubMed和Google Scholar。
  • 纳入2009年后发表、引用原始加速衰老假说或研究精神分裂症/精神病衰老的文献,最终纳入170篇。
  • 按领域进行叙述性综合,侧重荟萃分析和最少治疗、纵向队列。

主要发现

  • 精神分裂症显示可重复衰老表型:死亡率增加、痴呆风险升高、脑预测年龄升高和认知下降。
  • BrainAGE研究显示平均年龄差3-4年,常于首发时即存在。
  • 荟萃分析报告一致的端粒缩短(标准化均数差约-0.4至-0.5)和部分表观遗传时钟轻度加速。
  • 氧化应激、炎症、线粒体功能和胰岛素样生长因子-1信号失调频繁出现,部分先于抗精神病药暴露。

临床怎么用

  • 临床评估精神分裂症患者时应关注衰老相关共病、认知下降和痴呆风险。
  • 端粒长度和表观遗传时钟等生物标志物可能有助于识别提前衰老,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Schizophrenia has been proposed to be a disorder of accelerated ageing, characterised by a mismatch between biological and chronological age. Evidence accumulated over the past 15 years has examined this model using molecular, neuroimaging, cognitive and epidemiological markers. AIMS: To evaluate whether schizophrenia shows evidence of an accelerated or advanced ageing phenotype across biological systems and to assess the consistency of the underlying molecular mechanisms. METHOD: A systematic review (PROSPERO CRD42024574059) was conducted following PRISMA guidelines. PubMed and Google Scholar were searched for studies published after 2009 that cited the original accelerated ageing hypothesis publication or investigated ageing in the context of schizophrenia and/or psychosis. Evidence was synthesised narratively by domain, with emphases on meta-analyses and minimally treated, longitudinal cohorts. RESULTS: A total of 923 manuscripts were identified, and a final 170 were included in the systematic review. Schizophrenia showed a reproducible ageing phenotype, as evidenced by in increased mortality, higher dementia risk, brain-predicted age elevation and cognitive decline. BrainAGE studies revealed mean age gaps of 3-4 years, often present at first episode. At the mechanistic level, meta-analyses reported consistent telomere shortening (standardised mean difference approximately -0.4 to -0.5) and modest acceleration of selected epigenetic clocks. Dysregulation of oxidative stress, inflammation, mitochondrial function and insulin-like growth factor-1 signalling were frequent and partly preceded antipsychotic exposure. CONCLUSIONS: Schizophrenia is associated with a multisystem ageing phenotype underpinned by convergent biological mechanisms, most consistently involving telomere attrition and oxidative and/or inflammatory stress. The overall pattern supports a model of advanced rather than uniformly accelerated ageing, reflecting early biological deviation with parallel rather than steeper decline.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Fernandez-Egea E, Garcia-Rizo C, Kirkpatrick B, et al. Schizophrenia and accelerated ageing: systematic review and future research directions. Br J Psychiatry. 2026. PMID: 42015596. doi:10.1192/bjp.2026.10606

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。